Piper Sandler analyst Charles Neivert raised the firm’s price target on Westlake to $130 from $110 and keeps a Neutral rating on the shares after updating the firm’s model to incorporate data from Q4 earnings, 2023 guidance, revisions to the firm’s outlook for chemical industry fundamentals and initial estimates for 2024.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WLK: